Ad copy

Clinical Labs’ non-invasive prenatal test (NIPT) focuses on screening for the most common conditions, such as Down syndrome and DiGeorge syndrome, to provide accurate and clinically relevant results and greater peace of mind. ✅ Down syndrome (1 in 800 newborns) ✅ DiGeorge syndrome (1 in 1,000 newborns) – optional screening, additional cost applies DiGeorge syndrome (22q11.2 deletion) is the second most common cause of congenital heart disease and developmental delay after Down syndrome. If you’re expecting, ask your healthcare provider about Clinical Labs’ NIPT.